Objective:

To assess trends in substance use among U.S. adults, focusing on cannabis, nicotine, and other drugs through the Monitoring the Future (MTF) Longitudinal Panel Study.

Approach:

• Survey Methodology: The MTF Longitudinal Panel Study annually assesses self-reported drug use among U.S. adults aged 19 to 65.

Key Findings:

• Cannabis use among adults reached record-high levels in 2025.
• Nicotine vaping among young adults tripled in the past 30 days and nearly doubled in the past 12 months since 2017.
• Cigarette smoking rates remained low, with 8.3% in young adults and 10.6% in older adults.
• Heroin use among young adults increased from 0.2% in 2024 to 0.6% in 2025.
• Nonmedical use of sleeping medications among young adults rose from 2.0% in 2024 to 3.0% in 2025.
• Psychedelics usage among young adults decreased from 8.9% in 2024 to 7.2% in 2025.

Interpretation:

The findings indicate a shift in substance use patterns, with increasing cannabis and nicotine use, while traditional substances like alcohol and cigarettes show declining trends.

Limitations:

• The study relies on self-reported data, which may be subject to bias.
• The survey does not capture all demographic groups comprehensively.

Conclusion:

Ongoing surveillance is essential to understand the evolving drug landscape and inform public health interventions.

Sources:

• National Institute on Drug Abuse (NIDA)
• National Institutes of Health (NIH)